Provenance du réseau au premier degré de Syed Ali
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Joyant Pharmaceuticals, Inc.
 Joyant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Joyant Pharmaceuticals is a Dallas-based drug discovery company focused on the development of small molecule therapeutics for cancer. Their core competencies include chemical synthesis biochemistry, cell biology, and pharmacology. The focus of its company is on the development of unique chemical entities that operate by new cellular mechanisms. Its understanding of the molecular events that control the growth, replication, and apoptosis of human cells is becoming increasingly sophisticated. They intend to translate new knowledge of such pathways, and their misregulation in disease, into signaling-based targeted therapeutics.
3
| Private Company | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Syed Ali via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Alfred P. Sloan Foundation
 Alfred P. Sloan Foundation Miscellaneous Commercial ServicesCommercial Services Alfred P Sloan Foundation operates a non-profit organization. Its programs and interests are divided into five main areas as science & technology, standard of living & economic performance, education &careers in science & technology, selected national issues and the civic program. The foundation was established in 1934 and is headquartered in New York | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree | |
| Skidmore College | College/University | Undergraduate Degree | |
Diazon Pharmaceuticals, Inc.
 Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Founder |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 2 |
Sectorielle
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Founder | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
| Comptroller/Controller/Auditor | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Patrick G. Harran | 6 |
| Chris Farina | 1 |
| Donald Huffman | 1 |
